The gap between pharmacological screening and clinical translation has a structural explanation. Generic cell systems (usually) generate clean data — but they don't reflect the tissue environment, disease context, or signaling complexity that determines whether a compound actually works. This week's session examines what changes when you close that gap. Terry Hébert joins the Dr. GPCR community live on April 16 — one of 12+ Masterclasses planned for 2026, all included in Prem